Group
Created with Sketch.
Home
Our Community
XFactor Ventures
Graduate Syndicate
The Community Fund
AltrixBio
AltrixBio is an early stage company focused on advancing the company's lead platform: LuCI™ AJN 003, an oral drug that replicates the metabolic success of bariatric surgery in treatment of Type 2 Diabetes.
Location
Cambridge, MA
Website
altrixbio.com
Status
Active
Social
The AltrixBio Community
Nancy Briefs
Co-Founder, President & CEO
AltrixBio
Nancy Briefs
Co-Founder, President & CEO
AltrixBio
Chip Hazard
General Partner
Flybridge
Chip Hazard
General Partner
Flybridge
Jules Pieri
Founder and CEO
The Grommet
Jules Pieri
Founder and CEO
The Grommet
Back to Community
Sign up to stay in touch!
Submit